Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Miravant Medical Technologies    MRVT

MIRAVANT MEDICAL TECHNOLOGIES (MRVT)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 02/12 08:44:15 pm
1.0E-6 USD   --.--%
 SummaryQuotesChartsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
12/26/2017 12/27/2017 12/28/2017 12/29/2017 02/12/2018 Date
1.0E-5(c) 1.0E-5(c) 1.0E-5(c) 1.0E-6(c) 1.0E-6(c) Last
200 100 42 800 2 000 39 425 Volume
0.00% 0.00% 0.00% -90.00% 0.00% Change
More quotes
Company
Miravant Medical Technologies is a pharmaceutical research and development company which specializes in photodynamic therapy or PDT, a treatment modality based on drugs that respond to light. It develops light activated drugs and associated devices for photodynamic therapy through its novel... 
More about the company
Latest news on MIRAVANT MEDICAL TECHNOLOG

- No features available -

More news
Sector news : Biotechnology & Medical Research - NEC
02/22SANGAMO THERAPEUTICS : Surges on Therapy Collaboration Deal with Kite -- Market ..
DJ
02/22Sangamo in $3 billion gene-editing deal with Gilead
RE
02/15French pharma group Ipsen sees more asset purchases, U.S. growth
RE
02/15Oxford BioMedica wins second $100 million gene therapy contract
RE
02/14Bristol-Myers to pay $1.85 billion in cancer deal with Nektar
RE
More sector news : Biotechnology & Medical Research - NEC
Chart MIRAVANT MEDICAL TECHNOLOG
Duration : Period :
Miravant Medical Technolog Technical Analysis Chart | MRVT | US6046901079 | 4-Traders
Managers
NameTitle
David E. Mai President, Chief Executive Officer & Director
Michael Khoury Director
Kevin McCarthy Director
Thomas Herrick Director-Investor Relations
Sector and Competitors
1st jan.Capitalization (M$)
MIRAVANT MEDICAL TECHNOLOGIES0.00%0
CELLTRION, INC.--.--%34 966
IQVIA HOLDINGS INC2.41%20 749
LONZA GROUP-6.57%19 587
INCYTE CORPORATION-9.71%17 877
NEKTAR THERAPEUTICS39.74%13 613